2019 Specialty Rx Forum Agenda

Download the agenda


7:00 am REGISTRATION OPENS (Continental breakfast)
8:15 am - 8:30 am

Welcome and Opening Remarks

Mike Lonergan, President, Drug Management Solutions, Pharmaceutical Strategies Group
Sharon Frazee, PhD, MPH, Senior Vice President of Research and Data Innovation, PBMI
8:30 am - 9:15 am

Are You Ready for Next Generation Therapy?

Susan Trieu, PharmD, Director, Enterprise Specialty Clinical Solutions, MedImpact Health Systems

During this presentation, the speaker will discuss new drugs in the pipeline that will potentially revolutionize treatment in the near future. As a plan sponsor, are you prepared to evaluate, budget, and manage these innovative treatments?  Find out how to:

  • Predict the plan impact of newly approved drugs
  • Evaluate the efficacy of new versus existing treatments
  • Direct plan members to the most efficient therapies
9:15 am - 10:00 am

Managing Hemophilia: Patient, Provider, Pharmacist Perspectives

James Paist, Executive Director Hemophilia Foundation of Minnesota (HFMD)
Donald Glascock (patient)
Skye Peltier, Physician Assistant Childrens Minnesota Hematology Oncology
Anastasia Abramson, PharmD, Advanced Therapies Pharmacist Supervisor, AllianceRx Walgreens Prime

An estimated 20,000 people in the United States have hemophilia. Patients with this genetic disorder can suffer permanent damage if left untreated. During this interactive panel discussion, attendees will hear four perspectives on managing this rare disease:

  • Learn about the programs and services provided by the Hemophilia Foundation that help improve the quality of life for patients and their families affected by this genetic disorder
  • Gain insight into the challenges providers face with treating patients with this disorder
  • Understand the important role the pharmacist plays in helping manage this rare disease 
  • Hear a personal patient perspective on everyday life with hemophilia
10:00 am - 10:15 am  BREAK
10:15 am - 11:00 am 

New Alternatives to Specialty Drugs: Biosimilars & Specialty Generics Provide Hope for Controlling Cost and Improving Care for Complex Conditions

Christine Anderson, RPh, Vice President Specialty Products, EnvisionRx
Marly Arbuckle, RPh, CSP, Director Specialty Products and Affairs, MedTrakRx
Kelly Britt, RPh, Vice President Sales and Client Services, EnvisionPharmacies

Could a generic drug or biosimilar actually produce the same results at a fraction of the cost of the latest brand-name drug?

Overcoming skepticism of lower-cost alternatives is a major hurdle, especially when considering therapies for complex conditions such as cancer, MS, HIV, and the potential of organ rejection. A perceived lack of efficacy associated with generic and biosimilar alternatives compounds the resistance of switching to a generic version for life-sustaining drugs.

For plan sponsors and patients to realize the full potential for savings and improved health outcomes, plan sponsors need a thoughtful approach to biosimilars and specialty generics.

This presentation will walk through how the pharmacy care experience plays a pivotal role by sharing early experiences with biosimilars and specialty generics.
11:00 am - 11:45 am 

How to Get the Most Out of Your Specialty Contract

Gregory O. Callahan, MBA, Consultant, Milliman
Brian N. Anderson, MBA, Principal, Milliman

Are you leveraging every aspect of your 2019 specialty contract to receive the maximum financial benefit? Gain insight into the current 2019/2020 specialty tactics and pricing strategies, including the nuances of specialty performance guarantees. Learn how to craft a specialty contract that will make the most of discounts, rebates, and contract definitions.

12:00 pm - 1:00 pm  LUNCH PRESENTATION

Successes and Challenges in Specialty: A Plan Sponsor Perspective

This informal discussion, led by PSG’s Tracy Spencer, Senior Vice President, Employer Consulting, will feature representatives from The Boeing Company, Wells Fargo and Nissan.
1:00 pm - 1:30 pm 

Winning Strategies for Total Drug Management

Rae McMahan, MBA, Vice President & General Manager Enterprise Specialty, Prime Therapeutics

Specialty drugs account for 50 percent of total drug spend for most plan sponsors, including many treatments that process on the medical benefit. As specialty drug spend on the medical benefit drives up overall costs, payers need a total drug management strategy that looks at the full picture of drug therapy use and spend. In this session, we'll unpack what's required for total drug management and outline impactful levers plan sponsors can employ to move to lower net-cost drugs.
1:30 pm - 2:00 pm 

Delivering Specialty Pharmacy in the Community

Chris Creamer, Senior Director, Specialty Pharmacy Operations, Walgreen Co.

During this session, we'll discuss how a community-based specialty pharmacy can benefit the patient, provider, and plan sponsor. The session will:

  • Explain the difference between community-based specialty model vs. central-fill depot model
  • Discuss the impact a specialty pharmacy in the community can have on patient care
  • Explain the benefits of integrating the specialty pharmacist in with providers in the community
2:00 pm - 2:45 pm 

Enhancing Specialty Pharmacy Patient Experience Leveraging Technology to Drive Clinical Outcomes

Patty Taddei-Allen, PharmD, MBA, Director, Outcomes Research, WellDyneRx
Nick Page, PharmD, Chief Pharmacy Officer, WellDyneRx
Dan Sweeney, Vice President, Business Development, Relay Network

Providing an engaging patient experience is rapidly becoming a key differentiator in healthcare, an industry known for historically complex, slow-moving, and siloed systems. Attendees will understand how leveraging technology in their specialty drug management can enhance pharmacy-patient relationships for members. Through personalized mobile experiences with patients leading to improved onboarding, disease education, therapy onboarding, and refill and order management, patients more readily engage with their healthcare, leading to improved adherence and clinical outcomes.
2:45 pm - 3:00 pm BREAK
3:00 pm - 3:45 pm 

Improving Patient Care through Data and Devices

Christine Sawicki, RPh, MBA, LSSMB, Senior Director, Specialty Product Development, CVS Health

In this session, we'll look at how specialty pharmacy innovations are enhancing pharmaceutical care. The discussion will cover the challenges and opportunities of managing patients with complex needs using advanced analytics with data from connected devices. It will also explore patient interactions through integrated health records to enhance patient management for specific diseases. This data integration can support an enhanced patient experience, improved clinical outcomes, and better management of overall healthcare costs. The session will focus on how innovation breaks down barriers to pharmaceutical care and ultimately leads people on a path for better health.

3:45 pm - 4:15 pm 

Using Real World Data to Drive Better Outcomes and Lower Costs

Pramod John, PhD, CEO, VIVIO Health

Specialty drugs cost too much and often do not work as expected. The current supply chain and care models do not address the fundamental issues that have been plaguing the industry for decades. During this session, attendees will learn how using data can solve these problems resulting in better outcomes and lower costs. 
4:15 pm - 4:30 pm 

Closing Remarks 

Sharon Frazee, PhD, MPH, Senior Vice President of Research and Data Innovation, PBMI
  Subject to change